PALONOSETRON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Palonosetron, and what generic alternatives are available?
Palonosetron is a drug marketed by Accord Hlthcare, Avet Lifesciences, Baxter Hlthcare Corp, Chartwell Rx, Cipla, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Hospira, Meitheal, Mylan Institutional, Novast Labs, Qilu Pharm Hainan, Sagent Pharms Inc, Sandoz, Teva Pharms Usa, and Hikma. and is included in twenty NDAs.
The generic ingredient in PALONOSETRON is palonosetron hydrochloride. There are twenty-one drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the palonosetron hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Palonosetron
A generic version of PALONOSETRON was approved as palonosetron hydrochloride by SANDOZ on October 13th, 2015.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PALONOSETRON?
- What are the global sales for PALONOSETRON?
- What is Average Wholesale Price for PALONOSETRON?
Summary for PALONOSETRON
| US Patents: | 0 |
| Applicants: | 17 |
| NDAs: | 20 |
| Drug Prices: | Drug price information for PALONOSETRON |
| DailyMed Link: | PALONOSETRON at DailyMed |
US Patents and Regulatory Information for PALONOSETRON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 204615-001 | Mar 15, 2021 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Qilu Pharm Hainan | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 205648-001 | Sep 19, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Fresenius Kabi Usa | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | SOLUTION;INTRAVENOUS | 208109-001 | Nov 21, 2017 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
